Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Liver Neoplasms
×
cabozantinib
×
Clear all
Filters
3
NCT01908426
2021-05-06
CELESTIAL
Exelixis
Phase 3
Completed
707 enrolled
20 charts
1 FDA